Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07256704

Hypnosis and Attention in Patients With a Neurological Disease (Stroke, Traumatic Brain Injury and Multiple Sclerosis)

Led by Luzerner Kantonsspital · Updated on 2025-12-01

48

Participants Needed

1

Research Sites

193 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This feasibility study investigates the potential of hypnosis as a complementary therapy to improve attentional deficits and fatigue in patients with neurological diseases such as stroke, traumatic brain injury (TBI), and multiple sclerosis (MS). These patients often experience reduced spontaneous visual exploration and impaired functional independence despite current rehabilitation methods. By integrating hypnosis with standard care, and using EEG to monitor brain activity during hypnosis and sham-hypnosis sessions, this trial aims to evaluate the practicality, acceptability, and preliminary efficacy of hypnosis in enhancing attention and reducing fatigue.

CONDITIONS

Official Title

Hypnosis and Attention in Patients With a Neurological Disease (Stroke, Traumatic Brain Injury and Multiple Sclerosis)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • ICD-10 diagnosis of stroke, traumatic brain injury, or multiple sclerosis
  • Admitted as an inpatient or outpatient in the Clinic for Neurology and Neurorehabilitation
  • Age 18 years or older
  • Understanding of the German language
  • Written informed consent provided
Not Eligible

You will not qualify if you...

  • Presence of psychiatric disease
  • Scalp or skin conditions that interfere with EEG electrode placement (e.g., open wounds, infections, severe psoriasis)
  • Implanted medical or neurostimulation devices that interfere with EEG electrode placement (e.g., deep brain stimulators, cochlear implants)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Luzerner Kantonsspital

Lucerne, Switzerland

Actively Recruiting

Loading map...

Research Team

T

Thomas Nyffeler, Prof. Dr. med.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Hypnosis and Attention in Patients With a Neurological Disease (Stroke, Traumatic Brain Injury and Multiple Sclerosis) | DecenTrialz